InvestorsHub Logo
Followers 44
Posts 10460
Boards Moderated 0
Alias Born 01/13/2016

Re: None

Wednesday, 05/11/2016 12:00:36 AM

Wednesday, May 11, 2016 12:00:36 AM

Post# of 463774
TRIFECTA
1. Full 12/ & Interim-26/38/52 Week data confirms Piano Playing, Picture Painting, Striping in 150 Yds down the middle and sinking the 5 Footer..
2. Phase 2/3 Announded with FDA Guidance, Multi-National, Multi-Site December 2016, with chance for quick review at 6 months for Compassionate Care Approval like Aricept.
3. BP Partner to fund, manage, direct and market with Upfront Cash Fee to Anavex and NO LIMIT LIcensing Fees for new First In Class soon to be SOC for Alzheimers.

You think calling out three horses pays a lot for a little..Wait until the Anavex Tri-Fecta comes in..the Horses are on the track..
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News